Zimmer Biomet Holdings Inc
ZBH91.628USD
+0.347+0.38%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
18.13BMarktkapitalisierung
20.06KGV TTM
mehr Informationen über Zimmer Biomet Holdings Inc Unternehmen
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; biologics, sports medicine, extremities and trauma (S.E.T.) products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and ankle, among others.
Unternehmensinformationen
BörsenkürzelZBH
Name des UnternehmensZimmer Biomet Holdings Inc
IPO-datumJul 25, 2001
Gegründet am2001
CEOMr. Ivan Tornos
Anzahl der mitarbeiter17000
WertpapierartOrdinary Share
GeschäftsjahresendeJul 25
Addresse345 E Main St
StadtWARSAW
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl46580-2746
Telefon15742676131
Websitehttps://www.zimmerbiomet.com/en
BörsenkürzelZBH
IPO-datumJul 25, 2001
Gegründet am2001
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
48.85K
+5.46%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
20.42K
-4.67%
Mr. Mark Bezjak
Mr. Mark Bezjak
President - Americas
President - Americas
13.13K
+8.09%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
9.79K
-3.72%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
Mr. Arthur J. (Art) Higgins
Mr. Arthur J. (Art) Higgins
Independent Director
Independent Director
3.40K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
48.85K
+5.46%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
20.42K
-4.67%
Mr. Mark Bezjak
Mr. Mark Bezjak
President - Americas
President - Americas
13.13K
+8.09%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
9.79K
-3.72%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Apr 6
Währung: USDAktualisiert: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Knees
3.17B
41.33%
Hips
2.00B
26.03%
S E T
1.87B
24.30%
Other product category
640.30M
8.34%
Nach RegionUSD
Name
Umsatz
Anteil
United States
4.44B
57.81%
International
3.24B
42.19%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Knees
3.17B
41.33%
Hips
2.00B
26.03%
S E T
1.87B
24.30%
Other product category
640.30M
8.34%
Aktionärsstatistik
Aktualisiert: Sat, May 17
Aktualisiert: Sat, May 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.61%
Dodge & Cox
10.15%
T. Rowe Price Associates, Inc.
7.16%
BlackRock Institutional Trust Company, N.A.
5.63%
State Street Global Advisors (US)
4.42%
Other
61.03%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.61%
Dodge & Cox
10.15%
T. Rowe Price Associates, Inc.
7.16%
BlackRock Institutional Trust Company, N.A.
5.63%
State Street Global Advisors (US)
4.42%
Other
61.03%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
46.73%
Investment Advisor
38.22%
Hedge Fund
4.34%
Pension Fund
1.96%
Research Firm
1.75%
Bank and Trust
1.33%
Sovereign Wealth Fund
1.11%
Individual Investor
0.13%
Insurance Company
0.08%
Other
4.36%
Institutionelle Beteiligung
Aktualisiert: Mon, Jan 20
Aktualisiert: Mon, Jan 20
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
2020
187.66M
94.79%
-8.52M
2024Q4
2042
186.55M
93.71%
-18.21M
2024Q3
1986
185.93M
91.29%
-23.02M
2024Q2
1982
190.82M
92.76%
-16.12M
2024Q1
1974
190.22M
92.57%
-13.55M
2023Q4
1991
188.03M
89.99%
-18.28M
2023Q3
1984
188.24M
90.09%
-20.30M
2023Q2
2003
190.89M
91.52%
-16.92M
2023Q1
1993
190.05M
90.59%
-15.03M
2022Q4
1989
191.70M
91.35%
-15.71M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
22.80M
11.45%
-396.32K
-1.71%
Dec 31, 2024
Dodge & Cox
19.12M
9.6%
+2.04M
+11.98%
Dec 31, 2024
T. Rowe Price Associates, Inc.
14.35M
7.21%
+178.34K
+1.26%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
10.95M
5.5%
-351.66K
-3.11%
Dec 31, 2024
State Street Global Advisors (US)
8.98M
4.51%
-99.81K
-1.10%
Dec 31, 2024
American Century Investment Management, Inc.
5.92M
2.97%
-621.55K
-9.50%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.88M
2.45%
-2.32K
-0.05%
Dec 31, 2024
PRIMECAP Management Company
4.80M
2.41%
-174.23K
-3.50%
Dec 31, 2024
Van Eck Associates Corporation
3.96M
1.99%
+218.69K
+5.85%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Fri, Jun 6
Aktualisiert: Fri, Jun 6
Name
Anteil
Langar Global HealthTech ETF
5.66%
VanEck Morningstar Wide Moat Value ETF
4.53%
American Century Focused Large Cap Value ETF
3.05%
VanEck Morningstar Wide Moat ETF
2.3%
iShares U.S. Medical Devices ETF
2.21%
Cambria LargeCap Shareholder Yield ETF
1.82%
Invesco Bloomberg Pricing Power ETF
1.79%
First Trust Indxx Medical Devices ETF
1.68%
T Rowe Price Equity Income ETF
1.65%
SPDR S&P Health Care Equipment ETF
1.58%
Mehr Anzeigen
Langar Global HealthTech ETF
Anteil5.66%
VanEck Morningstar Wide Moat Value ETF
Anteil4.53%
American Century Focused Large Cap Value ETF
Anteil3.05%
VanEck Morningstar Wide Moat ETF
Anteil2.3%
iShares U.S. Medical Devices ETF
Anteil2.21%
Cambria LargeCap Shareholder Yield ETF
Anteil1.82%
Invesco Bloomberg Pricing Power ETF
Anteil1.79%
First Trust Indxx Medical Devices ETF
Anteil1.68%
T Rowe Price Equity Income ETF
Anteil1.65%
SPDR S&P Health Care Equipment ETF
Anteil1.58%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
996.70M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Aug 29, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 13, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
Jun 26, 2024
Jul 31, 2024
Jun 26, 2024
Feb 21, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 14, 2023
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 31, 2024
Dec 26, 2023
Aug 25, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2023 going ex on Sep 28, 2023 with reinvestment option
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 15, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2023 going ex on Jun 23, 2023 with reinvestment option
Jun 26, 2023
Jul 31, 2023
Jun 23, 2023
Mar 08, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 28, 2023 going ex on Mar 28, 2023
Mar 29, 2023
Apr 28, 2023
Mar 28, 2023
Dec 15, 2022
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 31, 2023
Dec 23, 2022
Aug 26, 2022
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 31, 2022
Sep 29, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
